Healthcare unicorn Ro is notifying employees of a data exposure involving their personal information after a security contractor “inadvertently” uploaded a spreadsheet of employee data to
Ro’s co-founder and chief growth officer Rob Schutz is stepping back from his current role and will stay involved with the digital health company in an advisory role, TechCrunch has learned. The sh
Digital health unicorns Ro, Cerebral, Calibrate and Forward's layoff stories share a through line that reveals the unique challenges of being a venture-backed healthcare business.
It’s nearly been two months since we started this accidental weekly column about layoffs happening within startups. Workforce reductions have impacted startup employees in every massive sector, from
Ro, a healthcare unicorn that last raised $150 million just months ago at a $7 billion valuation, has cut 18% of its staff to “manage expenses, increase the efficiency of our organization and better
Tusk Venture Partners, the now six-year-old, New York-based early-stage venture firm co-founded by longtime political strategist Bradley Tusk and former Blackstone director Jordan Nof, has closed its
Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast where we unpack the numbers and nuance behind the headlines. This week we recorded live, which is always good fun,
Modern Fertility co-founder Afton Vechery is leaving healthcare unicorn Ro about a year after her company, built alongside co-founder Carly Leahy, was sold for north of $225 million. According to an i
A week after healthcare unicorn Ro landed capital from existing investors at a higher valuation, two top executives have parted ways with the company, per an internal email obtained by TechCrunch from
Tech healthcare unicorn Ro announced today that it has raised $150 million exclusively from existing investors, led by ShawSpring Partners, with participation from FirstMark Capital, General Catalyst,
Ro, a direct-to-consumer health company valued by its investors at $5 billion, is nearing a deal to acquire at-home sperm storage upstart Dadi, per multiple sources familiar with the unicorn’s busin
Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast where we unpack the numbers behind the headlines. This is our Wednesday show, the time of the week when we niche down t
Ro, one of the most valuable privately owned health tech startups, isn’t subtle about its mission to deliver vertically integrated, affordable healthcare with consumers in mind. And while a patient-
Whether or not we’re at some kind of tipping point right now, venture investors, old and new, have done very well in recent years, with their limited partners notching the biggest gains in decad
Oova officially launched its Oova Kit that includes an at-home test that quantitatively measures two hormones, informing a woman — and her doctor — of her fertile days and confirming ovulation.
On this week’s episode of Found, we speak to Rob Schutz, co-founder and Chief Growth Officer at Ro. Ro recently raised $500 million, bringing its total raised to date to near $1 billion. The dig
Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines. For this week’s deep dive, Alex, Natasha and Chris dug into the wo
Hormones are key to solving many health conditions that disproportionately impact women, from diabetes to infertility to mental health challenges.
Ro, a digital elective care and telemedicine provider last valued at $5 billion, announced today that it has acquired Modern Fertility, a reproductive health company founded in 2017. Axios estimates
Companies like Ro and Hims have capitalized on the need for more seamless and discreet access to health and wellness products that are part of everyday life. For men. Stix is looking to do the same fo